Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in STTK — Shattuck Labs, Inc.

CIK 886982 NEW YORK, NY
Back to STTK Full portfolio

Position in STTK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,117,668
+$2,886,696 QoQ
Shares Held
593,324
+209.9% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 100 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in STTK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. STTK ranks #202 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in STTK

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,117,668 593,324
2026-03-31 $1,230,972 191,442
2025-12-31 $467,802 128,165
2025-09-30 $40,152 16,800
2025-06-30 $257,601 325,254
2025-03-31 $97,197 102,313
2024-12-31 $291,442 240,862
2024-09-30 $379,226 108,661
2024-06-30 $360,906 93,499
2024-03-31 $2,307,762 258,139
2023-12-31 $105,417 14,785
2023-03-31 $31,225 10,621
2022-12-31 $34,529 15,013
2022-09-30 $58,406 21,632
2022-06-30 $128,827 31,731
2022-03-31 $427,512 100,355
2021-12-31 $583,470 68,563
2021-09-30 $336,922 16,532
2021-06-30 $4,082,197 140,814
2021-03-31 $4,763,371 162,906